Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01411696 · ClinicalTrials.gov registry record
Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 289
- Enrollment target
NCT01411696: Completed study, sponsored by Allergan.
NCT01411696 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 289 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01411696 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 289 participants
- Enrollment target
Study Summary
This is a retrospective data collection study to evaluate the efficacy, safety, and re-injection interval of OZURDEX® in the treatment of macular edema due to RVO. Following informed consent, there were no patient study visits. All data was collected via chart review.
Primary Outcome
BCVA was assessed using the Snellen eye chart converted to Early Treatment Diabetic Retinopathy Study number of lines ranging from 0 (worst) to 20 (best). The change in BCVA was calculated using the most improved number of lines read correctly between 4 and 20 weeks following the last injection of OZURDEX® - the number of lines read correctly at baseline. A positive change from baseline indicates improvement.
Interventions
- DRUG dexamethasone intravitreal implant 0.7 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-03 |
What the finished NCT01411696 record still lists
NCT01411696 is an observational study that tracks outcomes without assigning an intervention. The registered 289 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which dexamethasone intravitreal implant 0.7 mg is the first listed.
NCT01411696 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01411696 about?
NCT01411696 is a clinical study titled "Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)". This is a retrospective data collection study to evaluate the efficacy, safety, and re-injection interval of OZURDEX® in the treatment of macular edema due to RVO. Following informed consent, there were no patient study visits. All data was collected via chart review.
What is the current status of trial NCT01411696?
This trial is currently completed. The enrollment target is 289 participants. The study started on 2011-07. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01411696?
The interventions under investigation include: dexamethasone intravitreal implant 0.7 mg (DRUG).
Who is sponsoring clinical trial NCT01411696?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06465199 · 289 participants · Phase 1
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia